Recently, the National Health Commission Clinical Testing Center (NCCL) announced the statistical results of the 2022 genetic disease high-throughput sequencing detection bioinformatics analysis inter-room quality evaluation activities, and Annoyouda Medical Testing Laboratory Co., Ltd. passed with full scores.
Interventional quality evaluation (referred to as interventional quality evaluation), also known as capability verification, is an internationally recognized important part of clinical laboratory quality management and an important part of quality management in medical institutions. The inter-room quality evaluation program of high-throughput sequencing detection of bioinformatics analysis can evaluate the bioinformatics analysis capabilities of high-throughput sequencing detection of genetic diseases in clinical laboratories and detection institutions.
This inter-ventricular quality evaluation Annoyouda 's excellent results also proves Annoyouda's strong strength in bioinformatics analysis and data interpretation.
Along the way, Annuoyouda adheres to its original aspirations and always provides accurate and reliable detection and analysis services to all parties with a rigorous attitude, striving to ensure the standardization of sequencing, analysis, and report interpretation. In the future, Annoyouda will continue to uphold the concept of "using technology and innovation to improve the quality of life" and strive to provide more scientific and accurate guarantees for clinical diagnosis and treatment.
